AUD 0.13
(-3.85%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -532.33 Thousand AUD | 87.36% |
2022 | -4.21 Million AUD | 89.16% |
2021 | -38.84 Million AUD | -1400.85% |
2020 | -2.58 Million AUD | 67.52% |
2019 | -7.96 Million AUD | -440.66% |
2018 | -1.47 Million AUD | -119.87% |
2017 | -670.39 Thousand AUD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -425.22 Thousand AUD | 93.13% |
2024 Q1 | -6.19 Million AUD | -1063.27% |
2023 Q3 | -12.4 Million AUD | -295.54% |
2023 FY | -532.33 Thousand AUD | 87.36% |
2023 Q4 | -532.33 Thousand AUD | 95.71% |
2023 Q2 | 6.34 Million AUD | 258.14% |
2023 Q1 | -4 Million AUD | 0.0% |
2022 Q3 | -24.92 Million AUD | 0.0% |
2022 Q1 | -38.84 Million AUD | 3.53% |
2022 Q2 | -24.92 Million AUD | 35.83% |
2022 FY | -4.21 Million AUD | 89.16% |
2021 Q3 | -2.86 Million AUD | -342.47% |
2021 Q4 | -40.26 Million AUD | -1306.4% |
2021 Q2 | -647.11 Thousand AUD | 75.0% |
2021 Q1 | -2.58 Million AUD | 39.43% |
2021 FY | -38.84 Million AUD | -1400.85% |
2020 Q4 | -4.27 Million AUD | -139.22% |
2020 FY | -2.58 Million AUD | 67.52% |
2020 Q3 | 10.89 Million AUD | 587.17% |
2020 Q2 | -2.23 Million AUD | -372.65% |
2020 Q1 | 820.35 Thousand AUD | 260.76% |
2019 Q2 | 1.47 Million AUD | 0.0% |
2019 FY | -7.96 Million AUD | -440.66% |
2019 Q4 | -510.28 Thousand AUD | 0.0% |
2018 FY | -1.47 Million AUD | -119.87% |
2017 FY | -670.39 Thousand AUD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Althea Group Holdings Limited | 641 Thousand AUD | 183.048% |
Cann Group Limited | 70.82 Million AUD | 100.752% |
ECS Botanics Holdings Ltd | -2.13 Million AUD | 75.05% |
Ecofibre Limited | 18.75 Million AUD | 102.838% |
Elixinol Wellness Limited | 554 Thousand AUD | 196.089% |
Hygrovest Limited | -189 Thousand AUD | -181.659% |
IDT Australia Limited | 3.96 Million AUD | 113.429% |
Invion Limited | -783.52 Thousand AUD | 32.059% |
Live Verdure Ltd | -1.08 Million AUD | 50.743% |
Medical Developments International Limited | -7.44 Million AUD | 92.854% |
Vitura Health Limited | -6.02 Million AUD | 91.17% |
Vita Life Sciences Limited | -24.24 Million AUD | 97.804% |